A recent study reveals significant gaps in cough management in India, highlighting excessive antibiotic use and a lack of ...

A recent study highlights improper categorization and treatment of cough in India. It emphasizes the overuse of antibiotics and fixed-dose combinations, urging a scientific approach to evaluation and ...

Citi lowered the firm’s price target on Kenvue (KVUE) to $20 from $22 and keeps a Neutral rating on the shares. The firm updated models in the beverages and home and personal care group. Citi favors ...

Trump administration to link children’s deaths with COVID-19 vaccine; Kenvue’s CEO lobbied RFK Jr.; NIH on track to spend its full budget by end of the month.

Recent health developments include the FDA's approval for Apple Watch hypertension features, Belgian contraceptive storage ...

The CEO of the company that makes Tylenol has directly pleaded with Robert F. Kennedy Jr. not to link the drug to autism.

The interim CEO and director of drugmaker Kenvue, which makes the common pain reliever Tylenol, met with US Health and Human ...

Seeking Alpha's roundup of statements, announcements and remarks that could impact markets, sectors and individual stocks.

Tylenol-maker Kenvue Inc. spoke with Health Secretary Robert F. Kennedy Jr. in a bid to keep the over-the-counter painkiller ...

Kenvue interim CEO Kirk Perry met privately this week with RFK Jr. to argue that there is no proven link between Tylenol and ...

The oral health initiative is targeted at 750,000 elementary school students and their families in rural communities and ...

He relayed the message Tuesday at a meeting of health care product makers and Wednesday to an FDA advocacy group. In addition ...